Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIT Pilot Trial for postpartum anaemia
ACTRN12622001105730Phase 4Not yet recruiting
- Sponsor
- The University of Auckland
- Start
- Sep 2022
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose and red blood cell transfusion in anaemia and iron deficiency anemia (IDA) (3 arms), sponsored by The University of Auckland. Primary endpoints: Number of women consenting to take part, Approached recruitment rate and 1 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
ferric carboxymaltosered blood cell transfusion
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12622001105730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001105730.